A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

Sponsors and Collaborators
Altor Bioscience Corporation
Florida Department of Health James and Esther King Biomedical Research

Contact
Virginia Rizzo, MS, LPN
321-841-4356
virginia.rizzo@orlandohealth.com

Principal Investigator
Charles J Rosser, M.D., MD Anderson Cancer Center Orlando

ClinicalTrials.gov Identifier
NCT01625260

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters